Get the Stockscreener App
0.00
100.00%
-100.99
After Hours:
101.03
101.03
+
Amedisys Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
See More
Previous Close:
$100.99
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$3.32B
Revenue:
$2.32B
Net Income/Loss:
$82.93M
P/E Ratio:
0.00
EPS:
2.52
Net Cash Flow:
$203.54M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$101.02
Amedisys Inc Stock (AMED) Company Profile
Name
Amedisys Inc
Sector
Industry
Phone
(225) 292-2031
Address
3854 AMERICAN WAY, BATON ROUGE, LA
Compare AMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMED
Amedisys Inc
|
0.00 | 3.32B | 2.32B | 82.93M | 203.54M | 2.52 |
|
HCA
Hca Healthcare Inc
|
484.77 | 110.07B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
199.40 | 17.38B | 20.69B | 2.40B | 1.55B | 15.62 |
|
UHS
Universal Health Services Inc
|
222.60 | 14.03B | 16.08B | 1.20B | 1.06B | 17.82 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.60 | 13.55B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
EHC
Encompass Health Corp
|
107.00 | 10.75B | 5.51B | 494.70M | 386.40M | 4.84 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-01-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-07-23 | Downgrade | Truist | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Mar-13-23 | Initiated | Barclays | Equal Weight |
| Oct-27-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-02-22 | Downgrade | UBS | Neutral → Sell |
| Jun-29-22 | Initiated | Stifel | Hold |
| Jun-21-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-01-22 | Upgrade | UBS | Sell → Neutral |
| Feb-25-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Feb-25-22 | Reiterated | Credit Suisse | Outperform |
| Feb-25-22 | Reiterated | Oppenheimer | Outperform |
| Feb-25-22 | Reiterated | RBC Capital Mkts | Outperform |
| Feb-25-22 | Reiterated | Raymond James | Outperform |
| Feb-25-22 | Reiterated | Truist | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-24-21 | Initiated | UBS | Sell |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-10-21 | Reiterated | The Benchmark Company | Buy |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-20-20 | Resumed | Barclays | Overweight |
| Jul-30-20 | Reiterated | The Benchmark Company | Buy |
| Jun-18-20 | Upgrade | The Benchmark Company | Hold → Buy |
| May-07-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-09-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Jan-17-20 | Initiated | Credit Suisse | Outperform |
| Nov-01-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-22-19 | Resumed | Stephens | Equal-Weight |
| Sep-17-19 | Initiated | Deutsche Bank | Buy |
| May-02-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-14-18 | Initiated | Barclays | Equal Weight |
| Nov-16-18 | Initiated | UBS | Neutral |
| Oct-30-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Jul-03-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-19-18 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Nov-09-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-08-17 | Reiterated | Mizuho | Buy |
| Nov-02-17 | Upgrade | The Benchmark Company | Hold → Buy |
| Aug-21-17 | Initiated | BofA/Merrill | Neutral |
View All
Amedisys Inc Stock (AMED) Latest News
UnitedHealth Clears Final Hurdle for Amedisys Acquisition with Historic Concessions - AD HOC NEWS
UnitedHealth Group (UNH) Stock This Week: DOJ-Amedisys Final Judgment, Fresh Legal Risks, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025) - ts2.tech
ACQUISITIONS & MERGERS—D. Md.:... - VitalLaw.com
DOJ: Settlement approved in UnitedHealth-Amedisys merger - Yahoo Finance
US Justice Department Says Court Approved Settlement In Unitedhealth Group And Amedisys Merger - TradingView — Track All Markets
UnitedHealth-Amedisys settlement with DOJ, states approved by US court - MLex
DOJ Requires Broad Divestitures, $1.1M Fine To Resolve UnitedHealth-Amedisys Merger Challenge: Retail Thinks It May Reduce Expected Synergies - MSN
How Amedisys Inc stock reacts to Fed rate cutsJuly 2025 Weekly Recap & Weekly High Momentum Picks - moha.gov.vn
Will Amedisys Inc. (ADY) stock attract long term capital inflowsWeekly Market Outlook & Technical Confirmation Trade Alerts - Newser
How Amedisys Inc. (ADY) stock reacts to new regulationsTrade Volume Summary & Weekly Top Gainers Alerts - Newser
How Amedisys Inc. (ADY) stock compares with tech leaders2025 Volatility Report & Daily Growth Stock Investment Tips - Newser
How Amedisys Inc. (ADY) stock performs during market turbulence2025 Stock Rankings & Expert Curated Trade Setups - Newser
Will Amedisys Inc. (ADY) stock outperform energy sector in 20252025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - Newser
Why Amedisys Inc. (ADY) stock is a must watch tickerEarnings Growth Report & Expert-Curated Trade Recommendations - Newser
Will Amedisys Inc. (ADY) stock profit from automation waveMarket Performance Summary & Verified Momentum Stock Alerts - Newser
How strong is Amedisys Inc. stock revenue growthMarket Activity Summary & Capital Protection Trade Alerts - Newser
Is Amedisys Inc. (ADY) stock a top dividend aristocrat candidateJuly 2025 Review & AI Enhanced Trade Execution Alerts - Newser
Why Amedisys Inc. (ADY) stock attracts wealthy investors2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - Newser
How Amedisys Inc. (ADY) stock responds to bond marketJuly 2025 Trends & Expert Approved Trade Ideas - BỘ NỘI VỤ
Pennant Group Flexes Acquisition ‘Muscle’ As It Integrates Amedisys, LHC Group Assets - Home Health Care News
What valuation ratios show for Amedisys Inc. (ADY) stock2025 Support & Resistance & Verified Short-Term Trading Plans - newser.com
ACQUISITIONS & MERGERS NEWS: Justice Department responds to public comments in HPE and United Health cases - VitalLaw.com
Is Amedisys Inc. (ADY) stock a momentum leaderJuly 2025 WrapUp & Free Long-Term Investment Growth Plans - newser.com
Using Python tools to backtest Amedisys Inc. strategies2025 Growth vs Value & Technical Pattern Based Buy Signals - newser.com
Using data filters to optimize entry into Amedisys Inc.July 2025 Patterns & Fast Moving Trade Plans - newser.com
Published on: 2025-11-19 20:53:55 - newser.com
Will Amedisys Inc. stock outperform growth indexesJuly 2025 Opening Moves & AI Optimized Trade Strategies - newser.com
What catalysts could drive Amedisys Inc. stock higherEntry Point & Short-Term Trading Opportunity Alerts - newser.com
Is a relief rally coming for Amedisys Inc. holdersJuly 2025 Spike Watch & Low Risk High Win Rate Picks - newser.com
Long term hold vs stop loss in Amedisys Inc.2025 Macro Impact & Free Accurate Trade Setup Notifications - newser.com
Can Amedisys Inc. stock maintain operating margins2025 Market Trends & Expert Curated Trade Ideas - newser.com
Amedisys Inc Stock (AMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):